Aviva’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Aviva's ABMD Position: Q4 2022 in Review
Aviva sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 12,519 shares — an estimated $3.08M sold.
Aviva first reported a position in ABMD in Q3 2018 and held it in 17 quarters. The position peaked at $9.23M in Q3 2018. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Aviva reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Aviva sold 12,519 Abiomed Inc shares in Q4 2022, an estimated $3.08M.
- Aviva first reported a position in Abiomed Inc in Q3 2018 and held it in 17 quarters.
- Aviva's Abiomed Inc position peaked at $9.23M in Q3 2018.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Aviva's 13F filing for Q4 2022, filed 9 Feb 2023.